Key Highlights
- Applied Optoelectronics signed an Equity distribution agreement for up to $550 million.
- Raymond James and Needham are involved in the program.
- SELLAS proposed a separate share offering after a trial-data jump.
- AMD and Broadcom rose while Micron and CoreWeave fell.
Applied Optoelectronics' program
Applied Optoelectronics (NASDAQ:AAOI), which makes optical networking components used in data centers, signed an equity distribution agreement on Wednesday, November 18, to sell up to $550 million of stock through Raymond James and Needham. Arrangements like this are commonly known as at-the-market, or ATM, programs. The company's shares slid during the session.
The agreement was the only company-specific news identified for the session. The wider AI hardware group was mixed on the day: AMD (NASDAQ:AMD) and Broadcom (NASDAQ:AVGO) rose, while Micron (NASDAQ:MU) and CoreWeave (NASDAQ:CRWV) fell.
How an ATM works
An at-the-market program lets a company sell new shares gradually into the open market at prevailing prices, through banks acting as sales agents. Unlike a traditional offering, which sells a large block of stock at once at a set price, an ATM gives the company flexibility to sell when and how much it chooses, up to the stated maximum. The company is not required to sell the full amount, and it can pause sales when market conditions are unfavorable. Many companies keep such programs in place for long periods as a standby source of funding.
ATMs are a routine financing tool, used by companies in many industries to raise money for operations, expansion or Debt reduction. But they can weigh on a stock because they add potential new supply. Investors may anticipate dilution, the spreading of a company's value over more shares, and adjust the price they are willing to pay.
SELLAS: a different kind of offering
SELLAS Life Sciences (NASDAQ:SLS), a biotech company, took a different route. It proposed a $150 million share offering after its stock jumped sharply on Tuesday on trial data. That is a conventional offering rather than an ATM, but it raises some of the same questions about new supply.
Biotech companies often raise money after positive news, since higher share prices let them sell fewer shares to raise the same amount of cash for research and trials.
Part of a broader trend
The two were among several Capital raises by smaller companies on Wednesday. Ardent Health (NYSE:ARDT) priced a secondary offering of 8 million shares at $14.50, Hyster-Yale (NYSE:HY) proposed a $125.0 million convertible notes offering, and Yesway (NASDAQ:YSWY) holders are selling 5 million shares in a secondary offering. CVR Energy (NYSE:CVI) and KBR (NYSE:KBR) launched debt offerings.
The broader small-cap market rose. The Russell 2000 gained 12.44 points to 2,714.31, and the S&P SmallCap 600 also rose. The S&P 500 slipped 16.90 points to 7,323.63, its fifth straight loss, while the Nasdaq Composite rose 101.50 points to 24,429.88.
At-the-Market Programs Raise a Dilution Question
For Applied Optoelectronics, investors will watch the company's future filings and quarterly reports, which typically disclose how much stock has been sold under an ATM program and at what prices. For SELLAS, the next step is pricing of the proposed offering, which will set the number of shares and the price. More broadly, the run of offerings on Wednesday will keep attention on how freely smaller companies can raise money with Volatility elevated and the Federal Reserve signaling more rate increases.



_11_19_2026_12_07_13_817193.jpg)


Please wait processing your request...